middle.news
How Argent’s CannPal Acquisition Could Accelerate CannEpil’s Global Reach
9:34am on Wednesday 14th of January, 2026 AEDT
•
Healthcare
Read Story
How Argent’s CannPal Acquisition Could Accelerate CannEpil’s Global Reach
9:34am on Wednesday 14th of January, 2026 AEDT
Key Points
Acquisition of 48% equity interest in CannPal for $2 million in RGT shares
Option secured to acquire Neuvis® drug-delivery platform intellectual property
Deal supersedes previous broader term sheet, focusing on core assets
Supports regulatory and commercial pathways for CannEpil® in Europe and beyond
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Argent Biopharma (ASX:RGT)
OPEN ARTICLE